Literature DB >> 21688290

Modulation of dopamine-dependent behaviors by the Caenorhabditis elegans Olig homolog HLH-17.

Chaquettea M Felton1, Casonya M Johnson.   

Abstract

In vertebrates and invertebrates, dopamine signaling modulates a wide variety of physical and behavioral functions and exerts these effects through heterotrimeric G proteins. The soil nematode Caenorhabditis elegans has been used to model dopamine signaling and reacts reproducibly to alterations in dopamine levels through eight well-characterized dopaminergic neurons located in the head. In C. elegans, the basic helix-loop-helix transcription factor HLH-17 is strongly and constitutively expressed in the glia cells that ensheath four of the dopaminergic neurons, yet it is not required for specification or development of either the glia or the neurons. In this study, we sought to determine whether HLH-17 functions in dopamine signaling. We found that, unlike wild-type animals, hlh-17 animals are resistant to the effects of exogenous dopamine on egg laying and mobility. hlh-17 animals are also defective in the basal slowing and gustatory plasticity behaviors that require functional dopamine signaling. We also found that the expression of the dopamine receptor genes dop-1, dop-2, and dop-3 and the RGS protein gene egl-10 is significantly reduced in hlh-17 animals. Together these results point to a role for HLH-17 in dopamine signaling in C. elegans.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688290     DOI: 10.1002/jnr.22694

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  IGDB-2, an Ig/FNIII protein, binds the ion channel LGC-34 and controls sensory compartment morphogenesis in C. elegans.

Authors:  Wendy Wang; Elliot A Perens; Grigorios Oikonomou; Sean W Wallace; Yun Lu; Shai Shaham
Journal:  Dev Biol       Date:  2017-08-10       Impact factor: 3.582

Review 2.  Evolution of the CNS myelin gene regulatory program.

Authors:  Huiliang Li; William D Richardson
Journal:  Brain Res       Date:  2015-10-22       Impact factor: 3.252

3.  Inferences of glia-mediated control in Caenorhabditis elegans.

Authors:  Stephanie N Bowles; Casonya M Johnson
Journal:  J Neurosci Res       Date:  2021-02-08       Impact factor: 4.164

Review 4.  Caenorhabditis elegans glia modulate neuronal activity and behavior.

Authors:  Randy F Stout; Alexei Verkhratsky; Vladimir Parpura
Journal:  Front Cell Neurosci       Date:  2014-03-14       Impact factor: 5.505

5.  A Caenorhabditis elegans locomotion phenotype caused by transgenic repeats of the hlh-17 promoter sequence.

Authors:  Randy F Stout; Vladimir Grubišić; Vladimir Parpura
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

6.  Genome-wide microarrray analysis reveals roles for the REF-1 family member HLH-29 in ferritin synthesis and peroxide stress response.

Authors:  Thanh K Quach; Han Ting Chou; Kun Wang; Gaolin Zheng Milledge; Casonya M Johnson
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

7.  HLH-29 regulates ovulation in C. elegans by targeting genes in the inositol triphosphate signaling pathway.

Authors:  Ana White; Abegail Fearon; Casonya M Johnson
Journal:  Biol Open       Date:  2012-02-08       Impact factor: 2.422

8.  A synergistic approach towards understanding the functional significance of dopamine receptor interactions.

Authors:  Pratima Pandey; Mahlet D Mersha; Harbinder S Dhillon
Journal:  J Mol Signal       Date:  2013-12-05

9.  Dopamine signaling in C. elegans is mediated in part by HLH-17-dependent regulation of extracellular dopamine levels.

Authors:  Chaquettea M Felton; Casonya M Johnson
Journal:  G3 (Bethesda)       Date:  2014-04-07       Impact factor: 3.154

10.  Caenorhabditis elegans male sensory-motor neurons and dopaminergic support cells couple ejaculation and post-ejaculatory behaviors.

Authors:  Brigitte LeBoeuf; Paola Correa; Changhoon Jee; L René García
Journal:  Elife       Date:  2014-06-10       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.